Peripheral carcinoid tumours of the lung: a clinicopathological study

Autor: Goel R, Bain Go, Abdi Ea, Bishop S

Publikováno v: Journal of surgical oncology. 39(3)

Peripheral carcinoid tumours (PCT) of the lung are a distinct entity. These tumours arise from subsegmental or distal bronchioles, are usually well circumscribed and encapsulated, and contain varying amounts of spindle cells. Their histogenesis is fr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16bf964a3b898f87555f726960238722
https://pubmed.ncbi.nlm.nih.gov/3184954

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial.

Autor: Stockler MR (AUTHOR), O'Connell R (AUTHOR), Nowak AK (AUTHOR), Goldstein D (AUTHOR), Turner J (AUTHOR), Wilcken NRC (AUTHOR), Wyld D (AUTHOR), Abdi EA (AUTHOR), Glasgow A (AUTHOR), Beale PJ (AUTHOR), Jefford M (AUTHOR), Dhillon H (AUTHOR), Heritier S (AUTHOR), Carter C (AUTHOR), Hickie IB (AUTHOR), Simes RJ (AUTHOR), Zoloft's Effects on Symptoms and Survival Time (ZEST) Trial Group (CORPORATE AUTHOR)

Publikováno v: Lancet Oncology. Jul2007, Vol. 8 Issue 7, p603-612. 10p.

Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: an exploratory analysis of TEXT and SOFT.

Autor: Regan MM; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston.; International Breast Cancer Study Group Statistical Center, Boston, USA., Walley BA; University of Calgary and Canadian Cancer Trials Group, Calgary, Canada., Francis PA; Division of Cancer Medicine, Peter MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne.; Australia & New Zealand Breast Cancer Trials Group and International Breast Cancer Study Group, Melbourne, Australia., Fleming GF; The University of Chicago Medical Center and Alliance for Clinical Trials in Oncology, Chicago, USA., Láng I; National Institute of Oncology and International Breast Cancer Study Group, Medical Oncology, Budapest, Hungary., Gómez HL; Division of Medicine, Instituto Nacional de Enfermedades Neoplásicas and International Breast Cancer Study Group, Lima, Peru., Colleoni M; Division of Medical Senology, European Institute of Oncology and International Breast Cancer Study Group, Milan., Tondini C; Medical Oncology, Ospedale Papa Giovanni XXIII and International Breast Cancer Study Group, Bergamo., Pinotti G; Medical Oncology, ASST Sette Laghi-Ospedale di Circolo and Fondazione Macchi and International Breast Cancer Study Group, Varese, Italy., Salim M; Allan Blair Cancer Center, Regina, Canada., Spazzapan S; Medical Oncology, Centro di Riferimento Oncologico and International Breast Cancer Study Group, Aviano, Italy., Parmar V; Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre and International Breast Cancer Study Group, Mumbai, India., Ruhstaller T; Breast Center St. Gallen, Swiss Group for Clinical Cancer Research (SAKK), St. Gallen.; International Breast Cancer Study Group, St. Gallen, Switzerland., Abdi EA; Australia & New Zealand Breast Cancer Trials Group and International Breast Cancer Study Group, The Tweed Hospital, Griffith University Gold Coast, Tweed Heads, Australia., Gelber RD; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston.; Harvard T.H. Chan School of Public Health, Frontier Science and Technology Research Foundation, Boston, USA., Coates AS; International Breast Cancer Study Group and University of Sydney, Sydney, Australia., Goldhirsch A; European Institute of Oncology and International Breast Cancer Study Group, Milan, Italy., Pagani O; Oncology Institute of Southern Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bellinzona.; International Breast Cancer Study Group, Lugano, Viganello, Switzerland.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2017 Sep 01; Vol. 28 (9), pp. 2225-2232.